Epigenetic Reprogramming Driven By Metabolic Alterations As A Mechanism Of EGFR – Tyrosine Kinase Inhibitor Resistance In Human Lung Adenocarcinoma

Authors :: Xu Zhang
Tapan K Maity
Abhilash Venugopalan
Daniel R. Crooks
Vikram Misra
Nitin Roper
Andrew N. Lane
Andresson Thorkell
King C. Chan
W. Marston Linehan
Udayan Guha
Khoa Dang Nguyen
Constance M. Cultraro
Yue Qi
Matthew Lynberg
Source :: The FASEB Journal. 34:1-1
Publication Year :: 2020
Publisher :: Wiley, 2020.

Subjects :: Chemistry
Mechanism (biology)
Inhibitor resistance
medicine.disease
Biochemistry
Human lung
medicine.anatomical_structure
Genetics
medicine
Cancer research
Adenocarcinoma
Molecular Biology
Reprogramming
Egfr tyrosine kinase
Biotechnology

Full Text Access

Tools